Steve Miller
Analyst · Brooke Roach at Goldman Sachs. Your line is open
Thanks Neil and Dave. I wanted to start by sharing just how excited I am to welcome all of you to our first earnings call. As you know, the company went public through direct listing roughly six weeks ago, and we couldn’t have done that without the support of all of our team members, customers, partners and investors, both existing and new. I also wanted to thank all the sell side analysts covering our stock who’ve taken the time to get to know the company dig into our numbers and share their perspectives on the business. As David Neil mentioned earlier, the vision Council measures the size of the optical market at roughly $42 billion, including prescription and non prescription glasses, contact lenses and eye exams, and Warby Parker accounts for just 1% of this market, representing tremendous room for growth ahead. I’ll start by talking about top line trends. We’re very happy with the top line momentum we’re seeing measured by revenue and customer growth. We’ve seen continued top line growth throughout each quarter this year. And we’re very pleased to report strong top line growth for Q3 2021 as well. In these remarks I’ll make comparisons were relevant to periods in 2020 and 2019. To address top line and bottom line trends versus periods pre pandemic in 2019 and versus the same period last year. Or Q3 2021m revenue came in at $137.4 million up 32% over last year and up 45% versus Q3 2019. Active customers increased to 2.1 million up 23% versus last year. This growth in top line was driven by a number of factors including a consistent replenishment cycle of our core prescription glasses offering, as well as impressive progress in our contact lens business, which still only represents 5% of our business overall. We’re also happy to report continued increases in average revenue per customer. We generated $242 in average revenue per customer on an LTM basis as of September 30, 2021. This represents a 14% increase over $213, measured as of the end of the same period last year. This growth in average revenue per customer illustrates our ability to execute on our holistic vision care strategy, where we are evolving from a glasses only company to one that meets the holistic vision care needs of all of our customers. And as we do so, we believe our customers will become even more loyal over time. Customers that purchase exams, contacts and glasses from us generate roughly 2.2 times the revenue after one year from initial purchase than glasses only customers. And yet holistic vision care purchasers continue to represent less than 1% of our active customers, underscoring the continued long term upside here. As Neil and Dave said, we very much view ourselves as an omni channel brand. Customer journeys are nuanced and complex, purchases that start online might end up in store and vice versa. And given that we strive to make customer experiences as seamless as possible across our stores, website and apps. For Q3 21, ecommerce represented 42% of our overall business versus 63% in 2020, and 34% in 2019. Today, our ecommerce mix from a channel perspective still remains moderately elevated versus 2019. Ecommerce grew at 102% in Q3 of last year. Compared to that period. Ecommerce is down 11% year over year, but up 80% versus 2019, representing a two year CAGR of 34%. We’re very pleased with our retail store performance. We’ve seen a strong recovery at our existing stores since the onset of the pandemic. And new stores are performing in line with the targets we’ve outlined including revenue per selling square foot for wall margin and pay back. We finished the quarter with 154 stores versus 123 stores open the same time last year, representing 31 new stores opened over the period. We opened nine new stores in Q3, 21 and 28 stores so far this year. We’re on track to open 35 new stores this year and we feel confident that our new store pipeline is stronger than ever. Next, I’ll shift gears to gross margin. Our gross margin is fully loaded and accounts for a range of costs including frames, lenses, optical labs, customer shipping, eye doctors, store rent and the depreciation of store build outs. As we talk about gross margin, we’ll continue to try and lay out the puts and takes that are reflected in changes to gross margin. As we discussed at our investor day in September, we expect our gross margins to fluctuate between quarters as a result of various puts and takes which includes seasonality and product mix. But on an annual basis, we’ve seen consistency of strong gross margins of 58% to 60%. We have some costs and benefits impacting comparability, which I’ll reference as well as a number of operating factors to bear in mind that reflect changes in gross margin. Gross margin for q3 2021 came in at 58%. This compares to 61.5% for the same quarter in 2020 and 60% in Q3 2019. Q3 2021 cost of goods sold includes stock compensation expense associated with our direct listing of 70 basis points related to our optometrists and optical lab employees, excluding this gross margin totaled 58.7%. In addition, q3 2020 benefited from a tariff rebate of approximately point 0.9% of revenue. With regards to the various operational puts and takes to gross margin, increased contact lens penetration accounted for the majority of a decrease we saw during the quarter. We saw contact lenses accelerate as a percentage of our business mix as we’ve driven brand awareness around that product offering. As Dave mentioned contacts are a $5 billion plus market and represent approximately 5% of our business today versus just 2% of our business for the full year 2020. Contact lenses have a lower margin profile than our core glasses offering but also have a higher purchase frequency that elevates gross margin dollars, particularly given the subscription like nature of this product line. We also saw moderate increases in the cost of air freight. We have little exposure to ocean freight trends as we use air for most of the products we directly purchase from overseas. Our product is lightweight and low volume, so these product costs make up a small minority of our overall costs. It’s also worth noting the impact of product mix on margin. In Q3 2021, we were pleased to see sales and non prescription sunglasses returned to pre pandemic levels of 10% plus of our business. During 2020, we saw sales of this product line dropped to half of pre pandemic levels, given sunglasses had moderately lower margins, this ultimately elevated gross margin in Q3 2020. We also opened our second optical lab in Las Vegas this quarter. As this new optical lab ramps to 100% operating capacity, we expect that it will continue to have a moderate drag on gross margin until the lab reaches scale in the latter part of next year. Once online, similar to results, we sold their first optical lab and slowed spurred, we expect to more efficiently serve our West Coast customers, resulting in higher NPS lower refund rates, faster turnaround time and improved gross margin overall. Next, we’d like to provide more visibility into SG&A for the quarter. The three main components of our SG&A line includes salary expense for our headquarters, customer experience and retail employees marketing spend, which includes our home Tryon [ph] program, and general corporate overhead expenses. First, we had a number of unique expenses associated with our direct listing recorded in SG&A. During the quarter, we recognize stock based compensation expense of $65 million transaction costs of $24 million, and a cost of 7$.8 million reflecting the start of our stock donations for charitable purposes to nonprofit organizations, including the Warby Parker impact foundation. As we expressed in connection with our long term model, we expect to see leverage across our SG&A spend as the driver of incremental adjusted EBIT down margin over time. In line with this framework, we maintained a very focused approach that enabled us to make continued investments in the business while generating leverage, excluding stock compensation expense and the one time costs associated with our direct listing, we saw SG& as a percent of revenue improve nearly six full points from 16.5% to 54.6%. This improvement was driven by two main factors. First, the thoughtful approach to hiring, making sure that incremental hires have clear alignment to supporting growth and infrastructure, and second is a disciplined deployment of marketing dollars. As it relates to marketing, we maintain a highly flexible model with the only committed spend largely around linear TV during competitive periods. Due to a range of factors including uncertainty in the broader economic environment as it related to COVID and some elevation of Meteor rates that we wanted to see settle, we maintained a conservative approach to the deployment of marketing spend as we leverage the flexibility of our model. In addition, we saw expense for our home Tryon program decrease as the mix between ecommerce and stores as normalized closer to pre pandemic levels. We were extremely pleased with our top line performance given our marketing spend growth was just mid single digits year over year in Q3. As we look ahead to Q4, we n to redeploy some of those dollars from q3 into q4 as we drive brand awareness and demand during the holiday season, and year end exploration of flexible spending. As it relates to adjusted EBITDA we saw an expansion of adjusted EBIT DOM margin in the quarter versus the same periods in 2020 and 2019. We generated adjusted EBITDA margin of 8.1% in the quarter versus 5.2% last year and 6.7% in 2019. This adjusted EBITDA margin is really a reflection of maintaining strong growth, while continuing to see leverage in SG&A. As just described. We finished the quarter with a strong balance sheet reflecting $266 million in cash, which will continue to deploy to make deliberate investments in both growth and infrastructure. Turning to our outlook for the remainder of the year, for the full year 2021, we now expect net revenue to be in the range of $539.5 million to $$542 million, representing growth of 37% to 38% versus 2020 and growth of 46% versus 2019. Adjusted EBITDA margin of approximately 4% to 5% in line with prior guidance, and we are on track to open 35 stores this year, which will bring our store count to 161. As we look ahead, it’s important to note that there are a number of unknowns related to the macro environment. As such, we continue to be thoughtful and prudent in setting our financial outlook for the balance of the year. Let me give you some color on the assumptions embedded within our guidance. As it relates to top line we observe moderately higher seasonal demand during the month of December due in part to customer usage of health and flexible spending benefits in the final weeks of the year. Given we recognize revenue upon delivery of product to the customer, we recognize revenue in Q1 for most orders placed in the final week of the year. From a seasonality perspective, Q4 is generally our lowest margin quarter as we make several investments to support the important holiday selling season. These investments include, marketing to support and generate customer demand, investments in shipping as we expedite orders to meet holiday timing, increasing store staffing to accommodate higher traffic and extended store hours and increasing our customer experience staffing to support higher demand, as well as elevated call volume related to flexible spending benefit questions. Or additional context, this demand from December, continues until January into Q1 which sets the stage for growth for the full year. Lastly, to be helpful ahead of our direct listing, we provided a framewok for 2022 net revenues growth and adjusted EBITDA margin improvement, we look forward to providing our formal 2022 outlook with our fourth quarter call in March. In closing, we built our business model with a focus on generating sustainable while driving incremental profitability of on to two points of adjusted EBITDA margin each year until we reach our long term adjusted EBITDA margin target of 20% plus. We could be more excited about what drive ahead,, thank you for welcoming us the public market, we’re thrilled to be here and with that, I am excited to open the call up to Q&A.